WO2005011663A8 - Utilisation d’un derive de biguanide pour proteger la peau des radiations uvb - Google Patents

Utilisation d’un derive de biguanide pour proteger la peau des radiations uvb

Info

Publication number
WO2005011663A8
WO2005011663A8 PCT/FR2004/002041 FR2004002041W WO2005011663A8 WO 2005011663 A8 WO2005011663 A8 WO 2005011663A8 FR 2004002041 W FR2004002041 W FR 2004002041W WO 2005011663 A8 WO2005011663 A8 WO 2005011663A8
Authority
WO
WIPO (PCT)
Prior art keywords
skin against
uvb radiation
protecting skin
biguanide derivative
against uvb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2004/002041
Other languages
English (en)
Other versions
WO2005011663A1 (fr
Inventor
Pierre Jean-Paul Potier
Nobumichi-Andre Sasaki
Maria Conception Achab
Gisele Franck
Joanna Bakala
Francoise Picot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMAMENS
Original Assignee
PHARMAMENS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMAMENS filed Critical PHARMAMENS
Priority to US10/566,490 priority Critical patent/US20070041915A1/en
Priority to EP04767816A priority patent/EP1686977A1/fr
Priority to JP2006521626A priority patent/JP2007500173A/ja
Priority to CA002534067A priority patent/CA2534067A1/fr
Publication of WO2005011663A1 publication Critical patent/WO2005011663A1/fr
Anticipated expiration legal-status Critical
Publication of WO2005011663A8 publication Critical patent/WO2005011663A8/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne l'utilisation d'un dérivé de biguanide pour protéger la peau contre les effets nocifs des radiations UVB et/ou pour protéger la peau contre les effets indésirables et/ou inesthétiques des radiations UVB.
PCT/FR2004/002041 2003-07-29 2004-07-29 Utilisation d’un derive de biguanide pour proteger la peau des radiations uvb Ceased WO2005011663A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US10/566,490 US20070041915A1 (en) 2003-07-29 2004-07-29 Use of a biguanide derivative for protecting skin against uvb radiation
EP04767816A EP1686977A1 (fr) 2003-07-29 2004-07-29 Utilisation d´ un derive de biguanide pour proteger la peau des radiations uvb
JP2006521626A JP2007500173A (ja) 2003-07-29 2004-07-29 Ｕｖｂ放射から皮膚を保護するためのビグアニド誘導体の使用
CA002534067A CA2534067A1 (fr) 2003-07-29 2004-07-29 Utilisation d'un derive de biguanide pour proteger la peau des radiations uvb

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0309306 2003-07-29
FR0309306A FR2858232B1 (fr) 2003-07-29 2003-07-29 Utilisation d'un derive de biguanide pour proteger la peau des radiations uvb

Publications (2)

Publication Number Publication Date
WO2005011663A1 WO2005011663A1 (fr) 2005-02-10
WO2005011663A8 true WO2005011663A8 (fr) 2006-03-23

Family

ID=34043630

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2004/002041 Ceased WO2005011663A1 (fr) 2003-07-29 2004-07-29 Utilisation d’un derive de biguanide pour proteger la peau des radiations uvb

Country Status (6)

Country Link
US (1) US20070041915A1 (fr)
EP (1) EP1686977A1 (fr)
JP (1) JP2007500173A (fr)
CA (1) CA2534067A1 (fr)
FR (1) FR2858232B1 (fr)
WO (1) WO2005011663A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0603252D0 (en) 2006-02-17 2006-03-29 Axcess Ltd Dissolution aids for oral peptide delivery
US8563500B2 (en) 2007-09-05 2013-10-22 Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Methods and compounds for treating diseases caused by reactive oxygen species
US20130059916A1 (en) * 2010-05-26 2013-03-07 Stephane Rocchi Biguanide compounds and its use for treating cancer
US11065188B2 (en) 2019-05-29 2021-07-20 Av Laboratories Llc Applications and formulations of optimized, modified human embryonic fertility culture media with biguanides and/or functional equivalents
CN112741825A (zh) * 2021-02-04 2021-05-04 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) 二甲双胍在制备治疗皮肤光损伤药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809310B1 (fr) * 2000-05-26 2004-02-13 Centre Nat Rech Scient Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant
GB0015205D0 (en) * 2000-06-21 2000-08-09 Karobio Ab Bioisosteric thyroid receptor ligands and method
EP1332146A2 (fr) * 2000-10-26 2003-08-06 Pfizer Products Inc. Inhibiteurs de metalloproteinase spiro-pyrimidine-2,4,6-trione
FR2822070B1 (fr) * 2001-03-15 2006-01-06 Andre Salkin Utilisation d'un derive de biguanide et d'une pyrimidine pour la fabrication d'une composition de soin cosmetique

Also Published As

Publication number Publication date
EP1686977A1 (fr) 2006-08-09
CA2534067A1 (fr) 2005-02-10
FR2858232A1 (fr) 2005-02-04
JP2007500173A (ja) 2007-01-11
FR2858232B1 (fr) 2006-03-03
US20070041915A1 (en) 2007-02-22
WO2005011663A1 (fr) 2005-02-10

Similar Documents

Publication Publication Date Title
AU2003226435A1 (en) Distal protection filter
AU2002244550A1 (en) Isolated bacteria for the protection of plants against phytopathogenic fungi and bacteria
AU2003273572A8 (en) Dedicated distal protection guidewires
EP1476471A4 (fr) Aliments fonctionnels pour le traitement, la protection et la restauration des tissus conjonctifs
WO2006003094A3 (fr) Derives de merocyanine
AU2003229923A1 (en) Curcumin for the prevention and/or treatment of tissue damage
EP1549163A4 (fr) Equipement de protection contre les insectes nuisibles
AU2003209286A1 (en) Auditory nerve protection and re-growth
AU2003281907A1 (en) Collimator and radiation irradiator
AU2003227489A1 (en) Skin protecting compositions
AU2003276129A1 (en) Compositions and methods for darkening the skin
WO2004026295A3 (fr) Utilisation de substances pour proteger la peau
AU2003288971A1 (en) Compositions for darkening the skin and/or hair
WO2005011663A8 (fr) Utilisation d’un derive de biguanide pour proteger la peau des radiations uvb
AU2003288972A1 (en) Compositions for darkening the skin and/or hair
WO2001047505A3 (fr) Utilisation d'azoles dans la prevention du cancer de la peau
HUP0303375A3 (en) Pharmaceutical and cosmetic compositions for the protection of the skin from damages induced by sun radiations
AU2003275809A1 (en) Roller curtain for protection of skin against mosquito or sunlight
IL154261A0 (en) Forearm protector against sunburn
IL157535A0 (en) Preparations for the prevention of skin atrophy
TWI365745B (en) Skin protecting composition
TW588586U (en) Protective structure for protecting human body from mosquito bites
AU2004906481A0 (en) A shield for protecting a part of the human body
HK1085401A (en) Treatment or prevention of damage due to radiation exposure
GB0508370D0 (en) Lotion for overall body and skin protection

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2534067

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2007041915

Country of ref document: US

Ref document number: 10566490

Country of ref document: US

Ref document number: 2006521626

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2004767816

Country of ref document: EP

CFP Corrected version of a pamphlet front page

Free format text: UNDER (54) PUBLISHED TITLE REPLACED BY CORRECT TITLE

WWP Wipo information: published in national office

Ref document number: 2004767816

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 10566490

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2004767816

Country of ref document: EP